Treatment of glaucoma using endothelin receptor antagonists | Patent Publication Number 20220257568

US 20220257568 A1

Patent NumberUS 11738007 B2

Application Number17733216

Filled DateApr 29, 2022

Priority DateOct 30, 2019

Publication DateAug 18, 2022

Original AssigneePerfuse Therapeutics Inc.

Current AssigneePerfuse Therapeutics Inc.

Inventor/ApplicantsDavid Floyd
Sevgi Gurkan

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.